Pharmacological agents to reduce readmissions in bipolar disorder

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

(2016) GM Goodwin et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records

(2016) Joseph F. Hayes et al.   World Psychiatry

Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials

(2015) Kirsten Bond et al.   BIPOLAR DISORDERS

Antidepressant therapy in cancer patients: initiation and factors associated with treatment

(2015) Sallie-Anne Pearson et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder

(2013) A. Cipriani et al.   ACTA PSYCHIATRICA SCANDINAVICA

Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial

(2013) Lars Vedel Kessing et al.   BRITISH JOURNAL OF PSYCHIATRY

Network meta-analysis, electrical networks and graph theory

(2012) Gerta Rücker   Research Synthesis Methods

Annual cost of managing bipolar disorder to the UK healthcare system

(2011) Allan H. Young et al.   JOURNAL OF AFFECTIVE DISORDERS

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

(2010)   LANCET

Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials

(2008) S Beynon et al.   JOURNAL OF PSYCHOPHARMACOLOGY